MKI67 and neoplasm: This is consistent with other studies (Bonadonna et al, 1990; Makris et al, 1997), but in contrast to data from other groups, which suggested that S-phase fraction (Remvikos et al, 1989), Ki-67 index (Bottini et al, 1996) or thymidine labelling index (Collecchi et al, 1998) predict clinical tumour shrinkage.